Protech Home Medical (CVE:PTQ) Shares Down 5.1% – Should You Sell?

Protech Home Medical Corp. (CVE:PTQ – Get Free Report) shares traded down 5.1% during mid-day trading on Monday . The company traded as low as C$8.04 and last traded at C$8.24. Approximately 184,783 shares were traded during trading, a decline of 59% from the average daily volume of 445,429 shares. The stock had previously closed at C$8.68.

Protech Home Medical Stock Performance

The firm’s 50-day moving average price is C$8.24 and its 200-day moving average price is C$8.24. The company has a debt-to-equity ratio of 85.53, a current ratio of 1.40 and a quick ratio of 1.12. The stock has a market cap of C$232.51 million and a P/E ratio of -179.13.

Protech Home Medical Company Profile

(Get Free Report)

Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp.

Read More

• Five stocks we like better than Protech Home Medical
• Buy CrowdStrike Before the Stock Split? Here’s the Case
• Investors Are Buying Into Sweetgreen Again—Should They?
• Burlington Is Winning Over Shoppers But Investors Need Patience
• USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk